All Curated Mutation Sites in HBV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
S
  
BCP
  
X
  
C
  
Core Promoter
  
Core Upstream Regulatory Sequence
  
DR1
  
EnhI
  
EnhII
  
PreC
  
P
  
PreC Promoter
  
PreS
  
PreS1
  
PreS1 Promoter
  
PreS2
  
RT
  
S Promoter
  
S1 Promoter
  
S2 Promoter
  
X Promoter
  

Keyword: Liver Diseases-15778957
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 15778957 G145R
S
S
Liver Diseases
G
C
View
2 15778957 T143M
S
S
Liver Diseases
G
C
View
3 15778957 T118V
S
S
Liver Diseases
G
C
View
4 15778957 G129H
S
S
Liver Diseases
G
C
View
5 15778957 P127T
S
S
Liver Diseases
G
C
View
6 15778957 S117R
S
S
Liver Diseases
G
C
View
7 15778957 A128V
S
S
Liver Diseases
G
C
View
8 15778957 K141D
S
S
Liver Diseases
G
C
View
9 15778957 P142R
S
S
Liver Diseases
G
C
View
10 15778957 T126S
S
S
Liver Diseases
G
C
View
11 15778957 G112R
S
S
Liver Diseases
G
C
View
12 15778957 C137X
S
S
Liver Diseases
G
C
View
13 15778957 C138X
S
S
Liver Diseases
G
C
View
Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.